Correlation Between Apellis Pharmaceuticals and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Arrowhead Pharmaceuticals.
Diversification Opportunities for Apellis Pharmaceuticals and Arrowhead Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apellis and Arrowhead is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.44 times less return on investment than Arrowhead Pharmaceuticals. But when comparing it to its historical volatility, Apellis Pharmaceuticals is 1.57 times less risky than Arrowhead Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 1,971 in Arrowhead Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 644.00 from holding Arrowhead Pharmaceuticals or generate 32.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Arrowhead Pharmaceuticals |
Apellis Pharmaceuticals and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Arrowhead Pharmaceuticals
The main advantage of trading using opposite Apellis Pharmaceuticals and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |